developmental therapeutics Phase I study of the pan-fibroblast growth factor receptor (FGFR) inhibitor BAY 1163877 with expansion cohorts for subjects based on tumor FGFR mRNA expression levels

Markus Joerger, Ross A. Soo, Byoung Chul Cho, Alejandro Navarro, Cyrus Sayehli, Heike Richly, David Tai, D.-W. Kim, Jennifer Moriatis Wolf, Philippe A. Cassier,

Annals of Oncology · 2016 · 10 citations · 0 references

Concepts